Zantac: Heartburn drug ranitidine’s possible cancer link investigated by California lab Emery Pharma

Zantac: Heartburn drug ranitidine’s possible cancer link investigated by California lab Emery Pharma

The popular heartburn drug ranitidine, the generic form of Zantac, was linked to cancer in September, prompting some voluntary recalls of the drug and an investigation by the Food and Drug Administration. A lab in California has also been working to get to th…
Read More

There are no reviews yet.

Be the first to review “Zantac: Heartburn drug ranitidine’s possible cancer link investigated by California lab Emery Pharma”

Your email address will not be published.

Quality
Price
Service